Market Tracker

10/30 6:00pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

During the Trading Day
94.72 +3.19 / +3.49%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
95.25 +0.53 / +0.56%
 
Volume: 4.4K

Today’s Trading

Previous close91.53
Today’s open90.96
Day’s range90.43 - 94.92
Volume466,563
Average volume (3 months)719,767
Market cap$7.0B
Dividend yield--
Data as of 3:59pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-268.14%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book21.58

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-1.69-2.91%
CBSTCubist Pharmaceutica...+1.15+1.61%
ISISIsis Pharmaceuticals...+0.87+1.93%
PRXLPAREXEL Internationa...-10.41-16.38%
Data as of 4:05pm ET, 10/30/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts